Phase 1 AIDS Clinical Trials

4 recruitingPhase 1

What is a Phase 1 trial?

Phase 1 trials test a new treatment in a small group of people for the first time. The primary goal is to evaluate safety, determine a safe dosage range, and identify side effects. These studies typically enroll 20 to 80 participants.

Showing 1–4 of 4 trials

Recruiting

Phase 1

Immune Cell Therapy (CAR-T) for the Treatment of Patients With HIV and B-Cell Non-Hodgkin Lymphoma

HIV InfectionRecurrent Non-Hodgkin LymphomaRefractory Non-Hodgkin Lymphoma+11 more

AIDS Malignancy Consortium20 enrolled6 locationsNCT05077527

Recruiting

Phase 1Phase 2

Mesenchymal Stem Cells Treatment for AIDS Patients at Late Stage

AIDS

Cell Energy Life Sciences Group Co. LTD150 enrolled4 locationsNCT05939167

Active

Phase 1

Study to evaluate the safety and immunogenicity of an HIV-1 vaccine regimen of adjuvanted UVAX-1107 followed by adjuvanted UVAX-1107 or adjuvanted UVAX-1197 in healthy subjects aged 25-55 years.

Acquired immune deficiency syndrome (AIDS / HIV)

Uvax Bio Australia, Pty, Ltd, a wholly owned subsidiary of Uvax Bio, LLC34 enrolled1 locationACTRN12624000064505

Recruiting

Phase 1

The Effect of Chimeric Antigen Receptor (CAR)-T Cell Therapy on the Reconstitution of HIV-specific Immune Function

HIV/AIDS

Guangzhou 8th People's Hospital40 enrolled1 locationNCT03240328